Vaxcyte, Inc.
PCVXCIK 0001649094 · last filing Jul 6, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
10,516 bought / 12,250 sold
net −1,734 sh · −$643.3K
- buys
- 2
- sells
- 5
- insiders active
- 2
Filing tape
Filed Mon, Jul 6, 2026
- −1,734 sh · $124.0K
Wassil Jim — CHIEF OPERATING OFFICER
- Exercised516Common Stock@ $5.35→ 159,010 held
- Sold1,788Common Stock@ $56.03→ 157,222 held
- Sold456Common Stock@ $57.47→ 156,766 held
- Sold6Common Stock@ $57.82→ 156,760 held
- Exercised516Stock Option (right to buy)→ 71,148 held
- −0 sh · $519.3K
Guggenhime Andrew — PRESIDENT AND CFO
- Exercised10,000Common Stock@ $5.35→ 114,395 held
- Sold7,913Common Stock@ $57.16→ 106,482 held
- Sold2,087Common Stock@ $57.76→ 104,395 held
- Exercised10,000Stock Option (right to buy)→ 226,827 held
Insiders on this tape
- Wassil JimCHIEF OPERATING OFFICER
- Guggenhime AndrewPRESIDENT AND CFO
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.